Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H1 is a member of the histone protein family, acting as a "linker" histone and binding to DNA regions between nucleosomes (the basic units of chromatin) in eukaryotic cells. Unlike the core histones (H2A, H2B, H3, H4) that form the nucleosome core, H1 stabilizes the structure by binding to the nucleosome and the connecting linker DNA, facilitating the folding of chromatin into higher-order structures such as the 30 nm fiber. H1 proteins are essential for chromatin organization and dynamics and play crucial roles in regulating gene expression, heterochromatin formation, and embryonic development. H1 exists in multiple subtypes with diverse post-translational modifications, which further regulate its function in chromatin structure and gene silencing. Its globular domain interacts with DNA, while its terminal regions contribute to nucleosome binding and stability. Dysregulation or abnormal expression of H1 family members has been implicated in several diseases, particularly cancers and epigenetic disorders. "Histone protein subunits H1" is not a single molecule or gene but a family of related proteins; thus, as a group, they are not a conventional drug target nor a typical receptor, enzyme, or transporter. There is no evidence of direct pharmacological targeting of H1 histones by any approved drugs. Individual subtypes (such as Histone H1.1, H1.2, etc.) might be studied in research contexts, but "H1" collectively is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H1 (H1).